← All Kamada LTD filings

Kamada LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
KMDA
Kamada LTD
20-F: Kamada and Kedrion Amend KEDRAB Distribution Agreement; Kamada Files Annual Report
Kamada Ltd. amends its KEDRAB distribution agreement with Kedrion Biopharma and files its annual report on Form 20-F.
NASDAQ
KMDA
Kamada LTD
20-F: Kamada Ltd. Reports FY2023 Results, Provides 2024 Guidance and Updates on Strategic Initiatives
Kamada Ltd. announces its FY2023 financial results, projecting double-digit growth for 2024 and highlighting key strategic advancements.